Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: A case study

Journal of Biomedical Optics

Volumn 10, Issue 5, 2005, Pages

  Shah, Natasha ^a,b   Gibbs, Jessica ^a,b   Wolverton, Dulcy ^a,b   Cerussi, Albert ^a,b   Hylton, Nola ^a,b   Tromberg, Bruce J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Frequency domain photon migration; Locally advanced breast cancer; Magnetic resonance imaging; Near infrared spectroscopy; Neoadjuvant chemotherapy; Therapeutic monitoring; Tissue optics

Indexed keywords

CHEMOTHERAPY; INFRARED SPECTROSCOPY; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; TUMORS;

BREAST CANCER; FREQUENCY DOMAIN PHOTON MIGRATION; LOCALLY ADVANCED BREAST CANCER; NEAR-INFRARED SPECTROSCOPY; NEOADJUVANT CHEMOTHERAPY; THERAPEUTIC MONITORING; TISSUE OPTICS;

ONCOLOGY;

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST TUMOR; CASE REPORT; FEMALE; HUMAN; IMAGE ENHANCEMENT; IMAGE SUBTRACTION; LASER; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL; CHEMOTHERAPY, ADJUVANT; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; LASERS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTRUM ANALYSIS; SUBTRACTION TECHNIQUE; TREATMENT OUTCOME;

EID: 33645455967     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.2070147     Document Type: Article

References (44)

1. K. K. Hunt, F. C. Ames, S. E. Singletary, A. U. Buzdar, and G. N. Hortobagyi, "Locally advanced noninflammatory breast cancer," Surg. Clin. North Am. 76(2), 393-410 (1996). (Pubitemid 26119156)
2. H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, "Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy," Ann. Surg. 230(1), 72-78 (1999). (Pubitemid 30190367)
3. H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, "Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy," J. Clin. Oncol. 17(2), 460-469 (1999). (Pubitemid 29075229)
4. T. A. Buchholz, K. K. Hunt, G. J. Whitman, A. A. Sahin, and G. N. Hortobagyi, "Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks," Cancer 98(6), 1150-1160 (2003). (Pubitemid 37099899)
5. J. Y. Pierga, E. Mouret, V. Laurence, V. Dieras, A. Savigioni, P. Beuzeboc, T. Dorval, T. Palangie, M. Jouve, and P. Pouillart, "Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical response," Eur. J. Cancer 39(8), 1089-1096 (2003). (Pubitemid 36555866)
6. C. Balu-Maestro, C. Chapellier, A. Bleuse, I. Chanalet, C. Chauvel, and R. Largillier, "Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI," Beitr. Tabakforsch. Int. 72(2), 145-152 (2002). (Pubitemid 34407209)
7. P. J. Drew, M. J. Kerin, T. Mahapatra, C. Malone, J. R. Monson, L. W. Turnbull, and J. N. Fox, "Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast," Eur. J. Surg. Oncol. 27(7), 617-620 (2001). (Pubitemid 33062166)
8. R. Gilles, J. M. Guinebretiere, C. Toussaint, M. Spielman, M. Rietjens, J. Y. Petit, G. Contesso, J. Masselot, and D. Vane, "Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy," Radiology 191(3), 633-638 (1994). (Pubitemid 24177877)
9. L. Esserman, N. Hylton, L. Yassa, J. Barclay, S. Frankel, and E. Sickles, "Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging," J. Clin. Oncol. 17(1), 110-119 (1999). (Pubitemid 29022384)
10. D. C. Abraham, R. C. Jones, S. E. Jones, J. H. Cheek, G. N. Peters, S. M. Knox, M. D. Grant, D. W. Hampe, D. A. Savino, and S. E. Harms, "Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging," Cancer 781, 91-100 (1996). (Pubitemid 26189909)
11. S. C. Partridge, J. E. Gibbs, Y. Lu, L. J. Esserman, D. Sudilovsky, and N. M. Hylton, "Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy," AJR, Am. J. Roentgenol. 1795, 1193-1199 (2002). (Pubitemid 35204372)
12. A. R. Padhani, "Contrast agent dynamics in breast MRI," in Breast MRI in Practice, R. Warren and A. Coulthard, Eds., pp. 43-54, Martin Dunitz, London (2002).
13. F. Bevilacqua, A. J. Berger, A. E. Cerussi, D. Jakubowski, and B. J. Tromberg, "Broadband absorption spectroscopy in turbid media by combined frequency-domain and steady-state methods," Appl. Opt. 3934, 6498-6507 (2000).
14. T. H. Pham, O. Coquoz, J. B. Fishkin, E. Anderson, and B. J. Tromberg, "Broad bandwidth frequency domain instrument for quantitative tissue optical spectroscopy," Rev. Sci. Instrum. 716, 2500-2513 (2000).
15. D. A. Mankoff, L. K. Dunnwald, J. R. Gralow, G. K. Ellis, M. J. Drucker, and R. B. Livingston, "Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using technetium 99 msestamibi scintimammography," Cancer 8511, 2410-2423 (1999). (Pubitemid 29244850)
16. P. Vaupel and M. Hockel, "Blood supply, oxygenation status and metabolic micromilieu of breast cancers: characterization and therapeutic relevance," Int. J. Oncol. 175, 869-879 (2000).
17. B. A. Teicher, "Hypoxia and drug resistance," Cancer Metastasis Rev. 132, 139-168 (1994). (Pubitemid 24220002)
18. A. E. Cerussi, A. J. Berger, F. Bevilacqua, N. Shah, D. Jakubowski, J. Butler, R. F. Holcombe, and B. J. Tromberg, "Sources of absorption and scattering contrast for near-infrared optical mammography," Acad. Radiol. 83, 211-218 (2001). (Pubitemid 32666460)
19. R. Cubeddu, C. D'Andrea, A. Pifferi, P. Taroni, A. Torricelli, and G. Valentini, "Effects of the menstrual cycle on the red and near-infrared optical properties of the human breast," Photochem. Photobiol. 723, 383-391 (2000).
20. N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B. Tromberg, "Noninvasive functional optical spectroscopy of human breast tissue," Proc. Natl. Acad. Sci. U.S.A. 988, 4420-4425 (2001). (Pubitemid 32294992)
21. S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, "Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography," Proc. Natl. Acad. Sci. U.S.A. 10021, 12349-12354 (2003). (Pubitemid 37271563)
22. B. J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler, "Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy," Neoplasia 21-2, 26-40 (2000). (Pubitemid 30123178)
23. B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen, "Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast," Radiology 2181, 261-266 (2001). (Pubitemid 32151305)
24. Q. Zhu, M. Huang, N. Chen, K. Zarfos, B. Jagjivan, M. Kane, P. Hedge, and S. H. Kurtzman, "Ultrasound-guided optical tomographic imaging of malignant and benign breast lesions: initial clinical results of 19 cases," Neoplasia 55, 379-388 (2003). (Pubitemid 37475646)
25. H. Dehghani, B. W. Pogue, S. P. Poplack, and K. D. Paulsen, "Multiwavelength three-dimensional near-infrared tomography of the breast: initial simulation, phantom, and clinical results," Appl. Opt. 421, 135-145 (2003).
26. V. Ntziachristos, A. G. Yodh, M. D. Schnall, and B. Chance, "MRIguided diffuse optical spectroscopy of malignant and benign breast lesions," Neoplasia 44, 347-354 (2002). (Pubitemid 34755845)
27. T. O. McBride, B. W. Pogue, S. Poplack, S. Soho, W. A. Wells, S. Jiang, U. L. Osterberg, and K. D. Paulsen, "Multispectral nearinfrared tomography: a case study in compensating for water and lipid content in hemoglobin imaging of the breast," J. Biomed. Opt. 71, 72-79 (2002). (Pubitemid 34278414)
28. D. B. Jakubowski, A. E. Cerussi, F. Bevilacqua, N. Shah, D. Hsiang, J. Butler, and B. J. Tromberg, "Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study," J. Biomed. Opt. 91, 230-238 (2004).
29. S. Merritt, F. Bevilacqua, A. J. Durkin, D. J. Cuccia, R. Lanning, B. J. Tromberg, G. Gulsen, H. Yu, J. Wang, and O. Nalcioglu, "Coregistration of diffuse optical spectroscopy and magnetic resonance imaging in a rat tumor model," Appl. Opt. 4216, 2951-2959 (2003).
30. B. W. Pogue, H. Zhu, C. Nwaigwe, T. O. McBride, U. L. Osterberg, K. D. Paulsen, and J. F. Dunn, "Hemoglobin imaging with hybrid magnetic resonance and near-infrared diffuse tomography," Adv. Exp. Med. Biol. 530, 215-224 (2003). (Pubitemid 37352363)
31. R. C. Haskell, L. O. Svaasand, T. Tsong-Tseh, F. Ti-Chen, M. S. McAdams, and B. J. Tromberg, "Boundary conditions for the diffusion equation in radiative transfer," J. Opt. Soc. Am. A 1110, 2727-2741 (1994).
32. A. M. K. Nilsson, C. Sturesson, D. L. Liu, and S. Andersson-Engels, "Changes in spectral shape of tissue optical properties in conjunction with laser-induced thermotherapy," Appl. Opt. 377, 1256-1267 (1998). (Pubitemid 128657366)
33. N. G. Chen, M. Huang, H. Xia, D. Piao, E. Cronin, and Q. Zhu, "Portable near-infrared diffusive light imager for breast cancer detection," J. Biomed. Opt. 93, 504-510 (2004).
34. N. Shah, A. E. Cerussi, D. B. Jakubowski, D. Hsiang, J. Butler, and B. J. Tromberg, "The role of diffuse optical spectroscopy in the clinical management of breast cancer," Dis. Markers 192-3, 95-105 (2004).
35. K. Wasser, H. P. Sinn, C. Fink, S. K. Klein, H. Junkermann, H. P. Ludemann, I. Zuna, and S. Delorme, "Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy," Eur. Radiol. 136, 1213-1223 (2003). (Pubitemid 36790621)
36. M. Kristoffersen Wiberg, P. Aspelin, M. Sylvan, and B. Bone, "Comparison of lesion size estimated by dynamic MR imaging, mammography and histopathology in breast neoplasms," Eur. Radiol. 136, 1207-1212 (2003). (Pubitemid 36790620)
37. P. S. Tofts, "Modeling tracer kinetics in dynamic Gd-DTPA MR imaging," J. Magn. Reson Imaging 71, 91-101 (1997). (Pubitemid 28365643)
38. L. Esserman, N. Hylton, T. George, and N. Weidner, "Contrastenhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma," Breast J. 51, 13-21 (1999). (Pubitemid 29108803)
39. K. Kinkel and N. M. Hylton, "Challenges to interpretation of breast MRI," J. Magn. Reson Imaging 136, 821-829 (2001). (Pubitemid 32479937)
40. W. M. Martin and N. J. McNally, "The cytotoxic action of adriamycin and cyclophosphamide on tumor cells in vitro and in vivo," Int. J. Radiat. Oncol., Biol., Phys. 58, 1309-1312 (1979). (Pubitemid 10163694)
41. B. Lennernas, P. Albertsson, H. Lennernas, and K. Norrby, "Chemotherapy and antiangiogenesis-drug-specific, dose-related effects," Acta Oncol. (Madr) 424, 294-303 (2003).
42. T. Browder, C. E. Butterfield, B. M. Kraling, B. Shi, B. Marshall, M. S. O'Reilly, and J. Folkman, "Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer," Cancer Res. 607, 1878-1886 (2000). (Pubitemid 30207647)
43. A. M. Shannon, D. J. Bouchier-Hayes, C. M. Condron, and D. Toomey, "Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies," Cancer Treat Rev. 294, 297-307 (2003). (Pubitemid 37069660)
44. D. J. Cuccia, F. Bevilacqua, A. J. Durkin, S. Merritt, B. J. Tromberg, G. Gulsen, H. Yu, J. Wang, and O. Nalcioglu, "In vivo quantification of optical contrast agent dynamics in rat tumors by use of diffuse optical spectroscopy with magnetic resonance imaging coregistration," Appl. Opt. 4216, 2940-2950 (2003).